Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Christine Rehm, MD
Sanofi
Disclosure(s): Sanofi: Employee, Stocks/Bonds (Public Company)
Poster(s):
(P-632) Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants and Toddlers
Thursday, October 17, 2024
12:15 PM – 1:30 PM
US PT
(P-662) Phase III, modified double-blind, randomized, parallel group, active-controlled, multi-center study of Meningococcal quadrivalent ACWY conjugated vaccine in infants from 6 through 23 months of age in the United States
Thursday, October 17, 2024
12:15 PM – 1:30 PM
US PT